Crosslinked Nucleoside Intermediate Crystal Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing synthesis methods for crosslinked nucleosides produce unstable reaction intermediates, making it challenging to stably store and industrially produce these compounds.
Innovation Solution
A crystal form of a crosslinked nucleoside intermediate is developed, characterized by specific substituents, which can be easily crystallized and stably stored, and a method involving protecting groups, conversion of dimethyldioxolanyl groups, and crystallization is used to produce this crystal, enabling the synthesis of a crosslinked nucleoside amidite.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If existing synthesis methods are used to produce crosslinked nucleoside intermediates, then the intermediates can be synthesized through a series of steps, but the intermediates are unstable and cannot be stored for long periods
Solution Approach 1:
The patent changes the physical state parameter of the crosslinked nucleoside intermediate from solution form to crystalline solid form. This phase change fundamentally alters the stability characteristics, enabling long-term storage while maintaining chemical integrity. The crystal structure provides a stable lattice that prevents degradation reactions.
Solution Approach 2:
The invention utilizes phase transition from liquid/solution to solid crystalline state to achieve stable storage. The crystallization process transforms the unstable intermediate into a stable crystalline form that can be stored indefinitely without degradation, effectively using phase change to resolve the stability-time contradiction.
2Ease of manufacture
If existing synthesis methods are used, then crosslinked nucleoside intermediates can be produced, but chromatographic purification is required which increases process complexity and time
Solution Approach 1:
The patent extracts and removes the chromatographic purification step from the synthesis process. By designing the synthesis to directly yield the crystalline intermediate, the harmful/complex purification operation is extracted and eliminated, simplifying the overall manufacturing process while maintaining product quality.
Solution Approach 2:
The crystalline crosslinked nucleoside intermediate performs self-purification through its inherent crystalline structure. The crystal lattice automatically excludes impurities during formation, eliminating the need for external chromatographic purification systems and reducing process complexity.
3Productivity
If existing synthesis methods are used, then crosslinked nucleoside intermediates can be synthesized, but the process requires multiple steps and time-consuming procedures
Solution Approach 1:
The patent performs preliminary crystallization during the synthesis process itself, rather than after. By inducing crystal formation in the reaction mixture at an appropriate stage, the intermediate is immediately stabilized in its crystalline form, eliminating subsequent purification time and accelerating the overall process.
Solution Approach 2:
The invention merges the synthesis step with the crystallization step into a single integrated process. Rather than separating synthesis and purification into distinct sequential operations, the method combines them so that the synthesis directly produces the crystalline intermediate, reducing total process time and improving productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The crystal form allows for long-term stable storage and industrial production of crosslinked nucleoside intermediates without the need for chromatographic purification, improving the stability and efficiency of nucleoside amidite synthesis.
Implementation Method 1
a crystal form of a crosslinked nucleoside intermediate is developed, characterized by specific substituents, which can be easily crystallized and stably stored
Data Source
AI summary
A crystal of a compound represented by the following formula 5:in which R1 represents a protecting group for a hydroxyl group, and R2 represents a leaving group.